Comorbidities associated with non- healing of plantar ulcers in leprosy patients.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
13
09
2019
accepted:
14
05
2020
revised:
10
07
2020
pubmed:
1
7
2020
medline:
15
8
2020
entrez:
30
6
2020
Statut:
epublish
Résumé
Non-healing plantar ulcers are one of the significant causes of disability in leprosy patients. Plantar ulcers often take months or years to heal, affecting the patient's quality of life. Presence of comorbid conditions in these patients can delay wound healing. The study aimed to evaluate the role of associated comorbid conditions as risk factors in ulcer healing. A total of 66 leprosy patients with plantar ulcers registered at LEPRA Society-Blue Peter Public Health and Research Center (BPHRC), Hyderabad, India from June 2018 to June 2019 were studied. Comprehensive clinical assessment was done, including screening for comorbid conditions and treated as per the recommended guidelines. About two-thirds of the participants were aged 50 and above, of which more than half were illiterates, and 93.5% were living below the poverty line. Majority of ulcers were seen on the forefoot; with the head of meta-tarsal bone 27 (41.6%) as the commonest site, followed by calcaneum 23 (38.3%) and great toe 10 (16.6%). Mean ulcer depth was 0.61 (0.57) cm, the area was 5.24 (6.73) cm2 and ulcer volume was 4.72 (14.33) cm3. Ulcer dimensions were significantly associated with low body mass index, hypertension and smoking. Identifying the risk factors delaying wound healing and detailed assessment of ulcers are of profound importance to predict the outcome of plantar ulcers in leprosy patients. The study findings indicate the need for better policies by the leprosy control program for the comprehensive management of plantar ulcers.
Sections du résumé
BACKGROUND
Non-healing plantar ulcers are one of the significant causes of disability in leprosy patients. Plantar ulcers often take months or years to heal, affecting the patient's quality of life. Presence of comorbid conditions in these patients can delay wound healing. The study aimed to evaluate the role of associated comorbid conditions as risk factors in ulcer healing.
METHODOLOGY/PRINCIPAL FINDINGS
A total of 66 leprosy patients with plantar ulcers registered at LEPRA Society-Blue Peter Public Health and Research Center (BPHRC), Hyderabad, India from June 2018 to June 2019 were studied. Comprehensive clinical assessment was done, including screening for comorbid conditions and treated as per the recommended guidelines. About two-thirds of the participants were aged 50 and above, of which more than half were illiterates, and 93.5% were living below the poverty line. Majority of ulcers were seen on the forefoot; with the head of meta-tarsal bone 27 (41.6%) as the commonest site, followed by calcaneum 23 (38.3%) and great toe 10 (16.6%). Mean ulcer depth was 0.61 (0.57) cm, the area was 5.24 (6.73) cm2 and ulcer volume was 4.72 (14.33) cm3. Ulcer dimensions were significantly associated with low body mass index, hypertension and smoking.
CONCLUSIONS/SIGNIFICANCE
Identifying the risk factors delaying wound healing and detailed assessment of ulcers are of profound importance to predict the outcome of plantar ulcers in leprosy patients. The study findings indicate the need for better policies by the leprosy control program for the comprehensive management of plantar ulcers.
Identifiants
pubmed: 32598386
doi: 10.1371/journal.pntd.0008393
pii: PNTD-D-19-01511
pmc: PMC7351235
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008393Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Infect Dis Poverty. 2017 Sep 4;6(1):105
pubmed: 28866982
Lepr Rev. 1964 Oct;35:267-72
pubmed: 14213610
Lepr Rev. 2005 Sep;76(3):220-31
pubmed: 16248209
PLoS Negl Trop Dis. 2015 May 12;9(5):e0003766
pubmed: 25965879
J Clin Diagn Res. 2016 Oct;10(10):WC06-WC09
pubmed: 27891436
Wkly Epidemiol Rec. ;92(35):501-19
pubmed: 28861986
Indian J Lepr. 2003 Jul-Sep;75(3):219-24
pubmed: 15267191
PLoS One. 2019 Apr 10;14(4):e0214861
pubmed: 30969978
Indian J Lepr. 2014 Apr-Jun;86(2):65-7
pubmed: 25591281
Indian J Plast Surg. 2012 May;45(2):340-51
pubmed: 23162234
Clin Microbiol Rev. 2015 Jan;28(1):80-94
pubmed: 25567223
Skinmed. 2017 Feb 01;15(1):45-51
pubmed: 28270310
J Cutan Aesthet Surg. 2017 Jan-Mar;10(1):3-7
pubmed: 28529413
Indian J Dermatol Venereol Leprol. 2018;84(2):131-136
pubmed: 29451189
PLoS Negl Trop Dis. 2016 May 24;10(5):e0004345
pubmed: 27219008
J Biomed Sci. 2017 Feb 27;24(1):16
pubmed: 28241824
BMC Infect Dis. 2010 Aug 10;10:237
pubmed: 20698989
Lepr Rev. 1991 Dec;62(4):381-8
pubmed: 1784153
PLoS One. 2014 Jan 27;9(1):e87423
pubmed: 24475286
Front Pharmacol. 2014 Jul 10;5:156
pubmed: 25071575